Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Cure Biopharma patents gemcitabine prodrugs for cancer

Nov. 25, 2020

Making exceptional responders unexceptional

Nov. 25, 2020

BCL6 degrader works via combine and conquer strategy

Nov. 24, 2020

Onconova files IND application with FDA for ON-123300

Nov. 24, 2020

Ascentage receives approval for phase Ib/II studies of APG-2575 in China

Nov. 24, 2020

Bio-Path studies BP-1002 in refractory or relapsed lymphoma and CLL

Nov. 23, 2020

Genfleet Therapeutics synthesizes KRAS inhibitors

Nov. 23, 2020

Beijing Jialin Pharmaceutical discloses new SMARCA2-targeting compounds

Nov. 23, 2020

Jiangsu Carefree Pharmaceutical synthesizes new tyrosine kinase receptors inhibitors

Nov. 20, 2020

Nanoparticle fights pancreatic cancer's chemo resistance

Nov. 20, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...